News

X4 Pharmaceuticals to Engage with Investors at Upcoming Conference

X4 Pharmaceuticals to Engage with Investors at Upcoming Conference

X4 Pharmaceuticals to Engage with Investors at Upcoming Conference

X4 Pharmaceuticals (Nasdaq: XFOR), a leader in developing therapies for rare immune diseases, is set to participate in the Stifel 2024 Healthcare Conference. This prestigious conference will take place in New York City on the 18th and 19th of November. It's an essential platform for the company to connect with investors and share their progress towards advancing patient care.

Conference Details

At the conference, X4 Pharmaceuticals will participate in a fireside chat scheduled for 4:10 PM ET on the first day. This format allows for an engaging discussion where key company representatives will showcase their latest developments and answer critical questions from the audience.

The conference presents an invaluable opportunity for X4 Pharmaceuticals to discuss their innovative therapies that aim to meet the significant unmet needs in the patient community. After the event, a live webcast replay will be available for those who wish to revisit the discussions and insights shared.

About X4 Pharmaceuticals

X4 Pharmaceuticals is deeply committed to improving the lives of patients with rare diseases affecting the immune system. They leverage their expertise in CXCR4 biology to develop mavorixafor, a medication Sapproved by the U.S. FDA as XOLREMDI, designed to treat specific conditions associated with this pathway.

The company continues to explore additional indications for mavorixafor, underscoring their dedication to research and development in addressing diverse medical needs. X4's headquarters are situated in Boston, Massachusetts, with a dedicated research center located in Vienna, Austria, emphasizing their global reach in scientific innovation.

Innovative Therapies for Rare Diseases

X4 Pharmaceuticals aims to drive significant advancements in therapeutic offerings for patients with rare immune diseases. With an unwavering focus on patient care, the company is at the forefront of developing advanced therapies that not only treat symptoms but aim for better health outcomes.

Connecting with Investors

During the Stifel conference, X4 Pharmaceuticals will also facilitate one-on-one meetings with interested investors. This approach enhances engagement and allows for deeper dialogues regarding the company's strategies, potential investments, and future projects.

Investors and stakeholders are encouraged to connect with their Stifel representatives to schedule these individualized discussions, ensuring a comprehensive understanding of X4's mission and vision.

Company Contacts for Further Information

For more information about X4 Pharmaceuticals, please reach out to:

José Juves
Head of Corporate & Patient Affairs
jose.juves@x4pharma.com

Daniel Ferry
Managing Director, LifeSci Advisors
Contact: (617) 430-7576
daniel@lifesciadvisors.com

Frequently Asked Questions

What is the purpose of the Stifel 2024 Healthcare Conference?

The conference is designed for biotech companies like X4 Pharmaceuticals to showcase their developments in therapies and connect with investors.

What date will X4 Pharmaceuticals participate in the conference?

X4 Pharmaceuticals will participate in the Stifel 2024 Healthcare Conference on November 18, 2024.

What is mavorixafor and its significance?

Mavorixafor is X4's innovative therapy approved by the U.S. FDA for treating rare diseases related to immune system deficiencies.

Where is X4 Pharmaceuticals headquartered?

X4 Pharmaceuticals is headquartered in Boston, Massachusetts, with a research center in Vienna, Austria.

How can investors learn more about X4 Pharmaceuticals?

Interested investors can contact the company directly via the provided emails or visit their official website for more information.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 254

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 127

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Beko Pushes for Policy Synergy Amidst Carbon Shakeup

Updated Category News Views 190

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Continue Reading
MV Transportation Celebrates Leadership Nomination for FTA

Updated Category News Views 192

MV Throws Support Behind Aesch for FTA Role In this wild world where public transit feels the heat from financial burdens, MV Transportation's recent move to support Mark Aesch for the Federal Transit Administration's top spot isn’t just a nod of approval—it's a full-blown trumpet blast. They're not just doling out a basic endorsement here; they're practically waving...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 155

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 410

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 139

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 186

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 143

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 155

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading

Top 5 Most Recently Viewed Articles

Class Action Lawsuit Against Joint Stock Company Kaspi.kz (KSPI)

Updated Category News Views 149

Understanding the Class Action Lawsuit Against Joint Stock Company Kaspi.kz Levi & Korsinsky, LLP has brought to light an important class action lawsuit concerning the Joint Stock Company Kaspi.kz (NASDAQ: KSPI). This initiative aims to provide legal recourse to investors who may have suffered due to alleged fraudulent activities that negatively impacted the company's...

Continue Reading
Verdafero Enhances Emission Reporting for Hospitality Sector

Updated Category News Views 133

Verdafero Launches New Emissions Reporting Service Verdafero, a prominent player in sustainability solutions, has introduced an expanded service for emissions reporting that now includes comprehensive tracking and analysis of Scope 1, Scope 2, and Scope 3 emissions specifically for the hospitality industry. This innovative offering provides businesses in this sector with...

Continue Reading
Analyst Ratings Spark Interest in GE Vernova and Peers

Updated Category News Views 187

Key Analyst Ratings for Prominent Stocks Wall Street analysts have recently begun covering some noteworthy companies, aiming to provide insights for potential investors. Analyst ratings can spark interest in stocks and guide buying decisions, especially when backed by thorough research. This article highlights the initiation of coverage on five significant stocks,...

Continue Reading
Repertoire Immune Medicines and Lilly Team Up on New Therapies

Updated Category News Views 210

Repertoire Immune Medicines and Eli Lilly Announce Collaboration Repertoire Immune Medicines is excited to announce a significant strategic collaboration with Eli Lilly and Company, focusing on the development of tolerizing therapies to treat various autoimmune diseases. This partnership is set to leverage Repertoire's advanced DECODE™ platform, designed to pioneer T...

Continue Reading
Manhattan Associates Faces Lawsuit Amid Significant Losses

Updated Category News Views 1108

Manhattan Associates Faces Lawsuit Amid Significant Losses A class action lawsuit has emerged against Manhattan Associates, Inc. (NASDAQ: MANH), a prominent player in software solutions for supply chain management and inventory operations. This legal action highlights concerns from investors who have experienced notable financial losses stemming from alleged...

Continue Reading